Reimbursement Strategic Planning

Reimbursement strategic planning is critical to the market success of your innovative technology. Many of the decisions you make early will have a tremendous impact on how Medicare and commercial payers cover and pay for your new product—and ultimately drive the success of your product upon commercialization.

By anticipating the reimbursement requirements associated with your technology and integrating with the clinical and regulatory requirements, you will optimize your chance for market success. RCRI can develop your product-specific reimbursement strategy that includes:

  • Clinical Study Design
    • Patient Outcomes
    • Economic Endpoints
    • Study Budgets
  • Reimbursement Feasibility Analysis
  • Alternative Treatment Options
    • Clinical Benefit
    • Cost
  • Coverage, Coding and Payment Assessment
  • Payer Mix Analysis
  • Payer Insights
  • Comprehensive Reimbursement Strategy, including Stakeholder Analysis
  • Pricing Strategy
  • Investor Presentation Development
Share Button

Regulatory and Clinical Research Institute

5353 Wayzata Boulevard, Suite 505, Minneapolis, MN 55416-1334 USA | | 952.746.8080

©2017 RCRI. All rights reserved.